MONNA NELMS: Open Payments
NPI 1205205317 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 50 payments from 14 companies in 2025. Trend: 2023 $1,590 · 2024 $1,494 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $204 |
| Novo Nordisk Inc | 14 | $169 |
| AstraZeneca Pharmaceuticals LP | 4 | $160 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Lilly USA, LLC | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Boston Scientific Corporation | 1 | $45 |
| Astellas Pharma US Inc | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: FARXIGA, VRAYLAR, Ozempic, QULIPTA, TRELEGY ELLIPTA, UBRELVY, INJECTAFER, WaveWriter Alpha Prime 16.
Industry payments across TN — which companies pay providers there.
